Chronic underfunding led to a drastic decision: the largest needle and syringe program operated by the NGO ARAS in Bucharest had to close down in February. Read this report from Alina Bocai, Programme Director at ARAS.
Needle and syringe programs
Activists from the United States look back on the history of the movement of people who use drugs in the fifth episode of the documentary series produced by INPUD and Drugreporter.
Drugreporter and INPUD present the fourth episode of an oral history of the movement of people who use drugs. This time we discover the vibrant user movement in South Africa.
Drugreporter and INPUD present the third instalment of an oral history of the movement of people who use drugs. This episode is about the achievement of drug user groups in Germany, Denmark, and Norway.
Drugreporter and INPUD presents the first episode of a 10 chapter long series documenting how people who use drugs around the world have organised and formed collectives and unions to protect and defend the health and human rights of their community. The first episode uncovers he history of the movement in the Netherlands, and how it inspired activists in Belgium and France.
The Hungarian drug market was affected by the COVID-19 crisis but it is far from being disrupted – read an English summary of an online survey conducted by Drugreporter among its Hungarian readers.
In this time of crisis, harm reduction activists must go beyond their regular demands and urge governments to act quickly to prevent a public health crisis transforming into a social collapse (Greek translation).
Although the drug strategy adopted by the Hungarian government in 2013 aimed to make the country drug-free by 2020, the (not so) new synthetic drugs still rule the country. After the municipal elections, there is some hope that harm reduction can return to Budapest.
Our report, based on the findings of research conducted among the clients of closed needle and syringe programs in Budapest and Belgrade, sheds light on the dire consequences of declining support for harm reduction in Central Eastern Europe.